Khirurgiia · 2025
[Middle segmental gastrectomy for stomach cancer].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ruchkin D V, Khamidov M M, Kozlov V A, Okonskaya D E, Karimova Sh Kh, Rymar O A
Аннотация
OBJECTIVE. T: O improve functional outcomes after surgical treatment of T1-2 gastric cancer.
MATERIAL AND METHODS: The study included 11 patients (5 males, 6 females; mean age 73±8.6 years) with T1-2N0M0 gastric cancer who underwent middle segmental gastrectomy with D2 lymphadenectomy. Selection criteria included tumor localization in gastric body, resection margins ≥6 cm, confirmed by intraoperative endoscopy. Proximal and distal gastric stumps were formed with anti-reflux fundoplication cuff. Quality of life (QoL) was assessed using EORTC QLQ-C30 and STO22 questionnaires.
RESULTS: No postoperative complications or mortality were observed. Mean surgery time was 220.4±54.4 min, blood loss - 390±186.8 ml. All resections were radical (R0). In long-term period (24.2±17.5 months), recurrence occurred in 1 patient (T3N0M0). Reflux esophagitis was absent; mild dumping syndrome was detected in 1 patient. QoL scores after surgery (functional scale - 92.7; symptom scale - 23.8) surpassed those after gastrectomy, pylorus-preserving, and distal subtotal resections.
CONCLUSION: Middle segmental gastrectomy demonstrates oncological adequacy and functional benefits (sphincter preservation, reduced reflux, and dumping syndrome). Further studies are required to confirm long-term outcomes.
MATERIAL AND METHODS: The study included 11 patients (5 males, 6 females; mean age 73±8.6 years) with T1-2N0M0 gastric cancer who underwent middle segmental gastrectomy with D2 lymphadenectomy. Selection criteria included tumor localization in gastric body, resection margins ≥6 cm, confirmed by intraoperative endoscopy. Proximal and distal gastric stumps were formed with anti-reflux fundoplication cuff. Quality of life (QoL) was assessed using EORTC QLQ-C30 and STO22 questionnaires.
RESULTS: No postoperative complications or mortality were observed. Mean surgery time was 220.4±54.4 min, blood loss - 390±186.8 ml. All resections were radical (R0). In long-term period (24.2±17.5 months), recurrence occurred in 1 patient (T3N0M0). Reflux esophagitis was absent; mild dumping syndrome was detected in 1 patient. QoL scores after surgery (functional scale - 92.7; symptom scale - 23.8) surpassed those after gastrectomy, pylorus-preserving, and distal subtotal resections.
CONCLUSION: Middle segmental gastrectomy demonstrates oncological adequacy and functional benefits (sphincter preservation, reduced reflux, and dumping syndrome). Further studies are required to confirm long-term outcomes.